cell wall synthesis inhibitors (Oscient Pharmaceutials)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namecell wall synthesis inhibitors (Oscient Pharmaceutials)
Drug Alias Namecell wall synthesis inhibitors (Genome Therapeutics)antibacterial (Genome Therapeutics)antibacterial (Oscient Pharmaceutials)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOscient Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOscient Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A